Rika Goda

716 total citations
7 papers, 567 citations indexed

About

Rika Goda is a scholar working on Oncology, Biomaterials and Pharmacology. According to data from OpenAlex, Rika Goda has authored 7 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Biomaterials and 3 papers in Pharmacology. Recurrent topics in Rika Goda's work include Nanoparticle-Based Drug Delivery (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Rika Goda is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Rika Goda collaborates with scholars based in Japan and United States. Rika Goda's co-authors include Iwao Nakamura, Kahori Shimizu, Yasuhiro Matsumura, Tsuyoshi Hamaguchi, Kazunori Kataoka, M. Yokoyama, Masanobu Suzuki, Tadao Kakizoe, Kiyohiro Nishikawa and Yoshio Aizawa and has published in prestigious journals such as British Journal of Cancer, International Journal of Nanomedicine and Drug Metabolism and Disposition.

In The Last Decade

Rika Goda

7 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rika Goda Japan	6	384	184	167	113	97	7	567
Abraham H. Abouzeid United States	8	399 1.0×	266 1.4×	313 1.9×	146 1.3×	39 0.4×	9	680
Min Hyo Seo South Korea	7	534 1.4×	269 1.5×	222 1.3×	188 1.7×	131 1.4×	12	835
Stephen Kalscheuer United States	8	260 0.7×	172 0.9×	287 1.7×	114 1.0×	37 0.4×	9	633
Noor Alam India	13	298 0.8×	153 0.8×	225 1.3×	140 1.2×	34 0.4×	14	574
Jian-Bin Qiao China	14	267 0.7×	268 1.5×	299 1.8×	58 0.5×	38 0.4×	20	811
Niravkumar R. Patel United States	15	606 1.6×	393 2.1×	540 3.2×	228 2.0×	65 0.7×	16	1.1k
Arthur Rekechenetskiy United States	7	444 1.2×	342 1.9×	335 2.0×	158 1.4×	51 0.5×	7	842
Luojuan Hu Australia	14	317 0.8×	152 0.8×	311 1.9×	178 1.6×	38 0.4×	23	757
Kunchi Zhang China	14	158 0.4×	275 1.5×	387 2.3×	99 0.9×	26 0.3×	26	761
Maja Thim Larsen Denmark	6	176 0.5×	104 0.6×	356 2.1×	108 1.0×	65 0.7×	6	655

Countries citing papers authored by Rika Goda

Since Specialization

Citations

This map shows the geographic impact of Rika Goda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Goda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Goda more than expected).

Fields of papers citing papers by Rika Goda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Goda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Goda. The network helps show where Rika Goda may publish in the future.

Co-authorship network of co-authors of Rika Goda

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Goda. A scholar is included among the top collaborators of Rika Goda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Goda. Rika Goda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Nakamura, Iwao, et al.. (2017). An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation. International Journal of Nanomedicine. Volume 12. 1293–1304. 16 indexed citations

2.

Mukai, Hirofumi, Ken Kato, Taito Esaki, et al.. (2016). Phase I study of NK105, a nanomicellar paclitaxel formulation, administered on a weekly schedule in patients with solid tumors. Investigational New Drugs. 34(6). 750–759. 27 indexed citations

3.

Matsuzaki, Yasushi, et al.. (2006). Metabolism and hepatic toxicity of flutamide in cytochrome P450 1A2 knockout SV129 mice. Journal of Gastroenterology. 41(3). 231–239. 34 indexed citations

4.

Goda, Rika, Yutaro Akiyama, Kiyohiro Nishikawa, et al.. (2006). DETECTION OF A NEW N-OXIDIZED METABOLITE OF FLUTAMIDE, N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]HYDROXYLAMINE, IN HUMAN LIVER MICROSOMES AND URINE OF PROSTATE CANCER PATIENTS. Drug Metabolism and Disposition. 34(5). 828–835. 44 indexed citations

5.

Hamaguchi, Tsuyoshi, Yasuhiro Matsumura, Masanobu Suzuki, et al.. (2005). NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. British Journal of Cancer. 92(7). 1240–1246. 436 indexed citations

6.

Watanabe, Noriko, et al.. (2001). In Vitro Effects of Fluoroquinolone Anti-bacterial Agents on Flutamide Metabolism in Human Liver Microsomes.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 32(2). 65–71. 6 indexed citations

7.

Watanabe, Noriko, et al.. (1997). Fast Quantitation of Drug Metabolites with a Small Amount. Quantitative Method for Hydroxytestosterone by GC/MS and Its Application for Measurement of P450 Enzyme Activity.. Journal of the Mass Spectrometry Society of Japan. 45(3). 367–375. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact